| Dr Michael S Chung, MD | |
|
23600 Telo Ave Ste 260, Torrance, CA 90505-4037 | |
| (424) 435-1037 | |
| (424) 435-1038 |
| Full Name | Dr Michael S Chung |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 17 Years |
| Location | 23600 Telo Ave Ste 260, Torrance, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053574608 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A112317 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of Gardena | Gardena, CA | Hospital |
| St Mary Medical Center | Long beach, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Oncology Institute Ca, A Professional Corporation | 5698872398 | 69 |
| Cancer And Blood Specialty Clinic | 9032260146 | 10 |
News Archive
The Republican lawmaker who will take the chair of the House's main investigative committee has made clear his interest in examining the overuse of expensive medical procedures while a newly tapped GOP subcommittee chief pledges to "dismantle Obamacare." Meanwhile, the food safety bill has been folded into must-pass legislation to fund the U.S. government.
American Civil Liberties Union on behalf of the Sexuality Information and Education Council of the United States and Advocates for Youth on Thursday sent a letter to HHS Secretary Mike Leavitt saying that the agency should enforce a federal law that states abstinence education must include "medically accurate" information about condom effectiveness, the Washington Times reports (Wetzstein, Washington Times , 4/27).
Scientists have speculated that this may be because the immune response is not strong enough, or because it does not last long enough to have an effect. Hence the increasing efforts to develop cancer vaccines that induce, strengthen, and increase the duration of immunological attack against cancer cells.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
› Verified 9 days ago
| Entity Name | The Oncology Institute Ca, A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275651515 PECOS PAC ID: 5698872398 Enrollment ID: O20070514000607 |
News Archive
The Republican lawmaker who will take the chair of the House's main investigative committee has made clear his interest in examining the overuse of expensive medical procedures while a newly tapped GOP subcommittee chief pledges to "dismantle Obamacare." Meanwhile, the food safety bill has been folded into must-pass legislation to fund the U.S. government.
American Civil Liberties Union on behalf of the Sexuality Information and Education Council of the United States and Advocates for Youth on Thursday sent a letter to HHS Secretary Mike Leavitt saying that the agency should enforce a federal law that states abstinence education must include "medically accurate" information about condom effectiveness, the Washington Times reports (Wetzstein, Washington Times , 4/27).
Scientists have speculated that this may be because the immune response is not strong enough, or because it does not last long enough to have an effect. Hence the increasing efforts to develop cancer vaccines that induce, strengthen, and increase the duration of immunological attack against cancer cells.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
› Verified 9 days ago
| Entity Name | Cancer And Blood Specialty Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538302351 PECOS PAC ID: 9032260146 Enrollment ID: O20090701000416 |
News Archive
The Republican lawmaker who will take the chair of the House's main investigative committee has made clear his interest in examining the overuse of expensive medical procedures while a newly tapped GOP subcommittee chief pledges to "dismantle Obamacare." Meanwhile, the food safety bill has been folded into must-pass legislation to fund the U.S. government.
American Civil Liberties Union on behalf of the Sexuality Information and Education Council of the United States and Advocates for Youth on Thursday sent a letter to HHS Secretary Mike Leavitt saying that the agency should enforce a federal law that states abstinence education must include "medically accurate" information about condom effectiveness, the Washington Times reports (Wetzstein, Washington Times , 4/27).
Scientists have speculated that this may be because the immune response is not strong enough, or because it does not last long enough to have an effect. Hence the increasing efforts to develop cancer vaccines that induce, strengthen, and increase the duration of immunological attack against cancer cells.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael S Chung, MD 23600 Telo Ave Ste 260, Torrance, CA 90505-4037 Ph: (424) 435-1037 | Dr Michael S Chung, MD 23600 Telo Ave Ste 260, Torrance, CA 90505-4037 Ph: (424) 435-1037 |
News Archive
The Republican lawmaker who will take the chair of the House's main investigative committee has made clear his interest in examining the overuse of expensive medical procedures while a newly tapped GOP subcommittee chief pledges to "dismantle Obamacare." Meanwhile, the food safety bill has been folded into must-pass legislation to fund the U.S. government.
American Civil Liberties Union on behalf of the Sexuality Information and Education Council of the United States and Advocates for Youth on Thursday sent a letter to HHS Secretary Mike Leavitt saying that the agency should enforce a federal law that states abstinence education must include "medically accurate" information about condom effectiveness, the Washington Times reports (Wetzstein, Washington Times , 4/27).
Scientists have speculated that this may be because the immune response is not strong enough, or because it does not last long enough to have an effect. Hence the increasing efforts to develop cancer vaccines that induce, strengthen, and increase the duration of immunological attack against cancer cells.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
› Verified 9 days ago
Deborah Chon, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 100, Torrance, CA 90505 Phone: 310-542-6333 | |
Erika Joyce Kalash, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 | |
Hosayn Khaleeli, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2245 Sepulveda Blvd, Torrance, CA 90501 Phone: 310-320-3204 Fax: 310-320-0919 | |
Mr. Anthony C Dike, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 20280 S Vermont Ave Ste 215, Torrance, CA 90502 Phone: 323-434-4626 Fax: 310-693-8082 | |
Paul J Brown, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3333 Skypark Dr, Torrance, CA 90505 Phone: 310-517-9006 | |
Dr. Philip W Chung, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lomita Blvd 215, Torrance, CA 90505 Phone: 310-379-2860 Fax: 310-325-1144 | |
Dr. Diane Jennifer Prager, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 300, Torrance, CA 90505 Phone: 310-325-8252 |